Predicting Response to Immunotherapy in Late-Stage Melanoma

A new model has the potential to identify patients with melanoma who could benefit from treatment with checkpoint inhibitors.

from Latest articles from Cancer Therapy Advisor Skin Cancer https://ift.tt/2OkUXrQ